REFERENCES
- Aggarwal, B. B., Bhardwaj, A., Aggarwal, R. S., et al. (2004). Role of resveratrol in prevention and therapy of cancer: Preclinical and clinical studies. Anticancer Res. 24: 2783–2840.
- Alcaín, F. J. and Villalba, J. M. (2009). Sirtuin activators. Expert. Opin. Ther. Pat.19: 409–414.
- Arfè, A., Malvezzi, M., Bertuccio, P., et al. (2011). Cancer mortality trend analysis in Italy, 1970–2007. Eur. J. Cancer Prev.20: 364–374.
- Bagnardi, V., Zatonski, W., Scotti, L., et al. (2008). Does drinking pattern modify the effect of alcohol on the risk of coronary heart disease? Evidence from a meta-analysis. J. Epidemiol. Community Health.62: 615–619.
- Bai, Y., Mao, Q. Q., Qin, J., et al. (2010). Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivo. Cancer Sci. 101: 488–493.
- Baur, J. A., Pearson, K. J., Price, N. L., et al. (2006). Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 444: 337–342.
- Baur, J. A. and Sinclair, D. A. (2006). Therapeutic potential of resveratrol: The in vivo evidence. Nat. Rev. Drug. Discov.5: 493–506.
- Boffetta, P. and Hashibe, M. (2006). Alcohol and cancer. Lancet Oncol.7: 149–156.
- Cagnasso, E., Rolle, L., Caudana, A., et al. (2008). Relationship between grape phenolic maturity and red wine phenolic composition. Ital. J. Food Sci.20: 365–380.
- Calabrese, E. J., Mattson, M. P. and Calabrese, V. (2010). Resveratrol commonly displays hormesis: Occurrence and biomedical significance. Hum. Exp. Toxicol.29: 980–1015.
- Cavallaro, A., Ainis, T., Bottari, C., et al. (2003). Effect of resveratrol on some activities of isolated and in whole blood human neutrophils. Physiol. Res.52: 555–562.
- Chao, H. H., Juan, S. H., Liu, J. C., et al. (2005). Resveratrol inhibits angiotensin II-induced endothelin-1 gene expression and subsequent proliferation in rat aortic smooth muscle cells. Eur. J. Pharmacol.515: 1–9.
- Chen, C. J., Yu, W., Fu, Y. C., et al. (2009). Resveratrol protects cardiomyocytes from hypoxia-induced apoptosis through the SIRT1-FoxO1 pathway. Biochem. Biophys. Res. Commun.378: 389–393.
- Crescente, M., Jessen, G., Momi, S., et al. (2009). Interactions of gallic acid, resveratrol, quercetin and aspirin at the platelet cyclooxygenase-1 level. Functional and modeling studies. Thromb. Haemost.102: 336–346.
- de la Lastra, C. A. and Villegas, I. (2007). Resveratrol as an antioxidant and pro-oxidant agent: Mechanisms and clinical implications. Biochem. Soc. Trans.35: 1156–1160.
- Doll, R., Peto, R., Boreham, J., et al. (2005). Mortality in relation to alcohol consumption: A prospective study among male British doctors. Int. J. Epidemiol.34: 199–204.
- El-Mowafy, A. M. and White, R. E. (1999). Resveratrol inhibits MAPK activity and nuclear translocation in coronary artery smooth muscle: Reversal of endothelin-1 stimulatory effects. FEBS Lett. 451: 63–67.
- Farchi, G., Fidanza, F., Giampaoli, S., et al. (2000). Alcohol and survival in the Italian rural cohorts of the Seven Countries Study. Int. J. Epidemiol.29: 667–671.
- Fernández, A. F. and Fraga, M. F. (2011). The effects of the dietary polyphenol resveratrol on human healthy aging and lifespan. Epigenetics. 6: 870–874.
- Fulgenzi, A., Bertelli, A. A., Magni, E., et al. (2001). In vivo inhibition of TNFalpha induced vascular permeability by resveratrol. Transplant Proc.33: 2341–2343.
- Giacosa, A., Adam-Blondon, A. F., Baer-Sinnott, S., et al. (2012). Alcohol and wine in relation to cancer and other diseases. Eur. J. Cancer Prev.21: 103–108.
- Grønbaek, M., Becker, U., Johansen, D., et al. (2000). Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer. Ann. Intern. Med.133: 411–419.
- Grønbaek, M., Deis, A., Becker, U., et al. (1998). Alcohol and mortality: Is there a U-shaped relation in elderly people? Age Ageing.27: 739–744.
- Harikumar, K. B. and Aggarwal, B. B. (2008). Resveratrol: A multitargeted agent for age associated chronic diseases. Cell Cycle.7: 1020–1035.
- Jin, F., Wu, Q., Lu, Y. F., et al. (2008). Neuroprotective effect of resveratrol on 6-OHDA induced Parkinsonø disease in rats. Eur. J. Pharmacol.600: 78–82.
- Kang, L., Heng, W., Yuan, A., et al. (2010). Resveratrol modulates adipokine expression and improves insulin sensitivity in adipocytes: Relative to inhibition of inflammatory responses. Biochimie.92: 789–796.
- Knoops, K. T., de Groot, L. C, Kromhout, D., et al. (2004). Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: The HALE project. JAMA.292: 1433–1439.
- Kweon, S. H., Song, J. H. and Kim, T. S. (2010). Resveratrol-mediated reversal of doxorubicin resistance in acute myeloid leukemia cells via downregulation of MRP1 expression. Biochem. Biophys. Res. Commun.395: 104–110.
- Landrault, N., Poucheret, P., Ravel, P., et al. (2001). Antioxidant capacities and phenolic levels of Franch Wines from Different Varieties and Vintages. J. Agric. Food Chem.49: 3341–3348.
- Liu, B. Q., Gao, Y. Y., Niu, X. F., et al. (2010). Implication of unfolded protein response in resveratrol-induced inhibition of K562 cell proliferation. Biochem. Biophys. Res. Commun.391: 778–782.
- Liu, J. C., Chen, J. J., Chan, P., et al. (2003). Inhibition of cyclic strain-induced endothelin-1 gene expression by resveratrol. Hypertension.42: 1198–1205.
- Marambaud, P., Zhao, H. and Davies, P. (2005). Resveratrol promotes clearance of Alzheimerø disease amyloid-beta peptides. J. Biol. Chem.280: 37377–37382.
- Meeran, S. M. and Katiyar, S. K. (2008). Cell cycle control as a basis for cancer chemoprevention through dietary agents. Front Biosci.13: 2191–2202.
- Mitrou, P. N., Kipnis, V., Thiébaut, I., et al. (2007). Mediterranean Dietary Pattern and Prediction of All-Cause Mortality in a US Population: Results From the NIH-AARP Diet and Health Study. Arch. Intern. Med.167: 2461–2468.
- Miura, T., Muraoka, S., Ikeda, N., et al. (2000). Antioxidative and prooxidative action of stilbene derivatives. Pharmacol. Toxicol.86: 203–208.
- Monagas, M., Bartolomè, B. and Gómez-Cordovés, C. (2005). Updated knowledge about the presence of phenolic compounds in wine. Crit. Rev. Food Sci. Nutr.45: 85–118.
- Mukherjee, S., Dudley, J. I. and Das, D. K. (2010). Dose-dependency of resveratrol in providing health benefits. Dose Response.8: 478–500.
- Palsamy, P. and Subramanian, S. (2009). Modulatory effects of resveratrol on attenuating the key enzymes activities of carbohydrate metabolism in streptozotocin-nicotinamide induced diabetic rats. Chem. Biol. Interact.179: 356–362.
- Palsamy, P. and Subramanian, S. (2010). Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic beta cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats. J. Cell Physiol.224: 423–432.
- Papoutsis, A. J., Lamore, S. D., Wondrak, G. T., et al. (2010). Resveratrol prevents epigenetic silencing of BRCA-1 by the aromatic hydrocarbon receptor in human breast cancer cells. J. Nutr.140: 1607–1614.
- Park, S. J., Ahmad, F., Philp, A., et al. (2012). Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell.148: 421–433.
- Penumathsa, S. V., Thirunavukkarasu, M., Zhan, L., et al. (2008). Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPKAkteNOS signalling pathway in diabetic myocardium. J. Cell Mol. Med.12: 2350–2361.
- Rehm, J., Sempos, C. T. and Trevisan, M. (2003). Alcohol and cardiovascular disease- more than one paradox to consider. Average volume of alcohol consumption, patterns of drinking and risk of coronary heart disease–a review. J. Cardiovasc Risk.10: 15–20.
- Smoliga, J. M., Baur, J. A. and Hausenblas, H. A. (2011). Resveratrol and health—a comprehensive review of human clinical trials. Mol. Nutr. Food Res.55: 1129–1141.
- Stervbo, U., Vang, O. and Bonnesen, C. (2007). A review of the content f the putative chemopreventive phytoalexin resveratrol in red wine. Food Chem.101: 449–457.
- Subbaramaiah, K., Chung, W. J., Michaluart, P., et al. (1998). Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem.273: 21875–21882.
- Suzuki, K. and Koike, T. (2007). Resveratrol abolishes resistance to axonal degeneration in slow Wallerian degeneration (WldS) mice: Activation of SIRT2, an NAD-dependent tubulin deacetylase. Biochem. Biophys. Res. Commun.359: 665–671.
- Tremacere, I., Pelucchi, C., Bonifazi, M., et al. (2012). A meta-analysis on alcohol drinking and risk of Hodgkin lymphoma. Eur. J. Cancer Prev.21: 268–273.
- Trichopoulou, A. and Critselis, E. (2004). Mediterranean diet and longevity. Eur. J. Cancer Prev.13: 453–456.
- Villalba, J. M. and Alcaín, F. J. (2012). Sirtuin activators and inhibitors. Biofactors.38: 349–359.
- Wang, T. T., Schoene, N. W., Kim, Y. S., et al. (2010). Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen- responsive LNCaP cancer cells. Mol. Nutr. Food Res.54: 335–344.
- Weyerer, S., Schäufele, M., Wiese, B., et al. (2011). Current alcohol consumption and its relationship to incident dementia: Results from a 3-year follow-up study among primary care attenders aged 75 years and older. Age Ageing.40: 456–463.
- Wu, C. C., Wu, C. I., Wang, W. Y., et al. (2007). Low concentrations of resveratrol potentiate the antiplatelet effect of prostaglandins. Planta Med.73: 439–443.
- Yang, Y. M., Wang, X. X., Chen, J. Z., et al. (2008). Resveratrol attenuates adenosine diphosphate-induced platelet activation by reducing protein kinase C activity. Am. J. Chin. Med.36: 603–613.
- Yu, W., Fu, Y. C. and Wang, W. (2012). Cellular and molecular effects of resveratrol in health and disease. J. Cell Biochem.113: 752–759.